The last ten years have witnessed a significant scale-up and access to antiretroviral therapy
in Africa, which has improved patient quality of life and survival. One major challenge …

Background. Drug resistance is a major barrier to successful antiretroviral treatment (ART).
Therefore, it is important to monitor time trends at a population level. Methods. We included …

Objectives There are few data on ART failure rates and drug resistance from Tanzania,
where there is a wide diversity of non-B HIV subtypes. We assessed rates and predictors of …

Objectives South Africa's national antiretroviral (ARV) treatment program expanded in 2010
to include the nucleoside reverse transcriptase (RT) inhibitors (NRTI) tenofovir (TDF) for …

Background. Accurate quantification of the prevalence of human immunodeficiency virus
type 1 (HIV-1) drug resistance in patients who are receiving antiretroviral therapy (ART) is …

Background Previous studies in human immunodeficiency virus (HIV)-positive individuals on
thymidine analogue backbone antiretroviral therapy (ART) with either nevirapine or …

The protease and reverse transcriptase (RT) genes were studied in antiretroviral (ARV)-
experienced and drug-naive HIV-I-infected individuals in Libreville, Gabon. We have shown …

Clinical, immunological and virological response to differen... : AIDS Clinical, immunological
and virological response to different antiretroviral regimens in a cohort of HIV-2-infected …

Background: There is concern that the expansion of antiretroviral roll-out may impact future
drug resistance levels and hence compromise the benefits of antiretroviral therapy (ART) at …

Objectives We aim to identify long-term trends in HIV drug resistance before and after
combined antiretroviral therapy (cART) initiation. Methods IAS-USA (2015) mutations were …